Navigating the dynamic landscape of biotech requires a robust financial strategy. Companies must carefully allocate resources to drive research and development, while also ensuring sustainability. This demands meticulous projection of income, coupled with a comprehensive approach to capital acquisition. Financial institutions scrutinize biotech com